Benecure was selected to compete in the American Heart Association Health Tech Competition at the Scientific Sessions. The Scientific Sessions is an annual conference for cardiovascular professionals and is attended by 15-17,000 cardiologists from a 100 different countries.
We were selected to compete in the competition because the AHA views as one of the innovative startups in the cardiovascular space.
We faced tough competition, all of the other teams had a presence in California and had venture funding ranging from $800K to $6 million, yet we were still able to give them a run for their money.
Initially, we tied for first place for audience favorite with Eko Devices. After a tie breaker we were given the second place spot for audience favorite despite being the most underfunded startup in the competition. We are proud to have represented the Chicago Health start-up community.
Our ability to compete with more established companies was noted. Several professionals and executives reached out to us and looking to help Benecure achieve the next milestone. We are gathering momentum, stay tuned for more updates.